Lundbeck's new drug application (NDA) for Vyepti® (eptinezumab) accepted by Japan's Ministry of Health, Labor and Welfare (MHLW), marking a significant step forward towards expanding access to the ...
Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated ...
23m
Vor Biopharma: Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Multiple Late-Stage Data Readouts Reinforce Telitacicept's Broad Potential Across Autoimmune DiseasesExpansion of Executive Leadership and Board Strengthens Global Development Capabilities Expected gr ...
Alnylam Pharmaceuticals has seen its Fair Value Estimate rise from $467.94 to $480.17, reflecting a modestly stronger outlook supported by recent analyst enthusiasm. This updated assessment comes ...
Northrop Grumman's market opportunities lie in its expansion of aerospace and defense technologies, particularly in military aircraft, space systems, and missile defense. Emphasis on digital ...
Share and Cite: Berlagosky, G. , Furer, T. and Silbering, J. (2025) Influence of Manipulative Marketing Tactics. Open Journal of Business and Management, 13, 4093-4113. doi: 10.4236/ojbm.2025.136222 .
As promised, Vivo has released the OriginOS 6 update for the Vivo X100 and X100 Pro in mid-November. The update is currently ...
OnePlus has officially launched its latest flagship smartphone, the OnePlus 15 in India. The phone comes with major upgrades in software, performance, camera, design, and battery. OxygenOS 16 With New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback